Contract with Approved Entity Pursuant to Sections 1860D-1 through 1860D-42 of the Social Security Act for the Operation of a Voluntary Medicare Prescription Drug Plan Between Centers for Medicare & Medicaid Services (hereinafter referred to as CMS) And WellCare Prescription Insurance, Inc. (S5967) (a Prescription Drug Plan Sponsor, hereinafter referred to as the PDP Sponsor)

EX-10.3 4 exhibit3.htm EX-10.3 EX-10.3

Exhibit 10.3

Contract with Approved Entity Pursuant to Sections 1860D-1 through 1860D-42 of
the Social Security Act for the Operation of a Voluntary Medicare Prescription
Drug Plan

Between

Centers for Medicare & Medicaid Services (hereinafter referred to as “CMS”)

And

WellCare Prescription Insurance, Inc. (S5967)
(a Prescription Drug Plan Sponsor, hereinafter referred to as the “PDP Sponsor”)

CMS and the PDP Sponsor, an entity that has been determined eligible to operate a Voluntary Medicare Prescription Drug Plan by the Administrator of CMS under
423 CFR §423.503, agree to the following for the purposes of sections 1860D-1 through 1860D-42. (with the exception of sections 1860D-22(a) and 1860D-31) of the Social Security Act (hereinafter referred to as “the Act.”)

Article I
Medicare Voluntary Prescription Drug Benefit

PDP Sponsor agrees to operate one or more Medicare Voluntary Prescription Drug Plans (hereinafter referred to as a “PDP”), as described in its application and related materials, including but not limited to all the attestations contained therein and all supplemental guidance, for Medicare approval and in compliance with the provisions of this contract, which incorporates in its entirety the Solicitation For Applications from Prescription Drug Plans released on January 21, 2005(as revised on March 9, 2005) (hereinafter collectively referred to as “the contract”). The PDP Sponsor also agrees to operate in accordance with the regulations at 42 CFR §423.1 through 42 CFR §423.910 (with the exception of Subparts Q, R, and S), sections 1860D-1 through 1860D-42 (with the exception of sections 1860D-22(a) and 1860D-31) of the Social Security Act, and the solicitation, as well as all other applicable Federal statutes, regulations, and policies. This contract is deemed to incorporate any changes that are required by statute to be implemented during the term of this contract and any regulations or policies implementing or interpreting such statutory provisions.

CMS agrees to perform its obligations to the PDP Sponsor consistent with the regulations at 42 CFR §423.1 through 42 CFR §423.910 (with the exception of Subparts Q, R and S), sections 1860D-1 through 1860D-42 of the Social Security Act (with the exception of sections 1860D-22(a) and 1860D-31) and the solicitation, as well as all other applicable Federal statutes, regulations, and policies.

CMS agrees that it will not implement, other than at the beginning of a calendar year, regulations under 42 CFR Part 423 that impose new, significant regulatory requirements on the PDP Sponsor. This provision does not apply to new requirements mandated by statute.

This contract is in no way intended to supersede or modify 42 CFR, Part 423. Failure to reference a regulatory requirement in this contract does not affect the applicability of such requirements to the PDP Sponsor and CMS.

Article II
Functions to be Performed by the PDP Sponsor

A. ENROLLMENT

PDP Sponsor agrees to accept new enrollments, make enrollments effective,

process voluntary disenrollments, and limit involuntary disenrollments, as
described in 42 CFR, Part 423, Subpart B.

PDP Sponsor agrees to comply with the prohibition in 42 CFR 423.104(b) on discrimination in beneficiary enrollment.

PDP Sponsor agrees to provide the basic prescription drug coverage as defined under 42 CFR §423.100 and, to the extent applicable, supplemental benefits as defined in 42 CFR §423.100 and in accordance with Subpart C of 42 CFR Part 423. PDP Sponsor also agrees to provide Part D benefits as described in the PDP Sponsor’s bid(s) approved each year by CMS (as referenced in Attachment A, to be replaced each year upon renewal of the contract to reflect the Sponsor’s approved bids for the succeeding contract year).

PDP Sponsor agrees to calculate and collect beneficiary premiums in accordance with 42 CFR §§423.286 and 423.293.

DISSEMINATION OF PLAN INFORMATION

PDP Sponsor agrees to provide the information required in 42 CFR §423.48.

PDP Sponsor agrees to disclose information to beneficiaries in the manner and the form specified by CMS under 42 CFR §§423.128, 423.50 and in the “Marketing Materials Guidelines for Medicare Advantage-Prescription Drug Plans (MA-PDs) and Prescription Drug Plans (PDPs),” and to comply with requirements in 42 CFR §423.50 requiring certain approvals of marketing materials prior to distribution.

PDP Sponsor certifies that all materials it submits to CMS under the File and Use Certification authority described in the Marketing Materials Guidelines are accurate, truthful, not misleading, and consistent with CMS marketing guidelines.

QUALITY ASSURANCE/UTILIZATION MANAGEMENT

PDP Sponsor agrees to operate quality assurance, drug utilization management, and medication therapy management programs, and to support electronic prescribing in accordance with Subpart D of 42 CFR Part 423.

APPEALS AND GRIEVANCES

PDP Sponsor agrees to comply with all requirements in Subpart M of 42 CFR Part 423 governing coverage determinations, grievances and appeals, and formulary exceptions.

PAYMENT TO PDP SPONSOR

PDP Sponsor and CMS agree that payment under this contract will be governed by the rules in Subpart G of 42 CFR Part 423.

If the PDP Sponsor is participating in the Part D Reinsurance Payment Demonstration, described in 70 FR 9360 (Feb. 25, 2005) it affirms that it will not seek payment under the demonstration for services provided to employer group enrollees.

PDP Sponsor agrees that it is bound by all applicable federal laws and regulations, guidance, and authorities pertaining to claims and debt collections. In the event that the government determines that the PDP Sponsor has been overpaid, the PDP Sponsor agrees to return those overpaid monies back to the federal government.

BID SUBMISSION AND REVIEW

If the PDP Sponsor intends to participate in the Part D program for the next program year, PDP Sponsor agrees to submit the next year’s bid, including all required information on premiums, benefits, and cost-sharing, by the applicable due date, as provided in Subpart F of 42 CFR Part 423 so that CMS and the Part D plan sponsor may conduct negotiations regarding the terms and conditions of the proposed bid and benefit plan renewal.

STATE LAW AND LICENSURE REQUIREMENTS

PDP Sponsor agrees to comply with State law to the extent that it is not preempted by Federal law as described in Subpart I of 42 CFR Part 423.

PDP Sponsor agrees that where it is operating in a State using a waiver granted pursuant to 42 CFR §423.410, such waiver shall be valid for three consecutive program years. PDP Sponsor agrees that expiration of the licensure waiver (and the failure to obtain a license from the relevant State) may be the basis for CMS deleting from the PDP Sponsor’s service area those PDP Regions affected by the waiver expiration. CMS may terminate or non-renew the PDP Sponsor’s contract where the expiration of the waiver results in the PDP Sponsor not being qualified to offer a PDP plan in any PDP Region.

PDP Sponsor agrees that where it is operating in a State using a waiver granted pursuant to 42 CFR §423.415, such waiver shall be valid for the period that the Secretary of the Department of Health and Human Services determines is appropriate for timely processing of the PDP Sponsor’s license application by the State, but in no case no more than one year only, beginning on January 1 of the contract year for which CMS granted the waiver.

COORDINATION WITH OTHER PRESCRIPTION DRUG COVERAGE

PDP Sponsor agrees to comply with the coordination requirements with State Pharmacy Assistance Programs (SPAPs) and plans that provide other prescription drug coverage as described in Subpart J of 42 CFR Part 423.

PDP Sponsor agrees to comply with Medicare Secondary Payer procedures as stated in 42 CFR §423.462.

SERVICE AREA AND PHARMACY ACCESS

The PDP Sponsor agrees to provide Part D benefits in the service area for which it has been approved by CMS utilizing a pharmacy network and formulary approved by CMS that meet the requirements of 42 CFR §423.120.

The PDP Sponsor agrees to provide Part D benefits through out-of-network pharmacies according to 42 CFR §423.124.

PDP Sponsor agrees to provide benefits by means of point of service systems to adjudicate prescription drug claims in a timely and efficient manner in compliance with CMS standards, except when necessary to provide access in underserved areas, I/T/U pharmacies (as defined in 42 CFR §423.100), and long- term care pharmacies (as defined in 42 CFR §423.100).

PDP Sponsor agrees to contract with any pharmacy that meets the PDP Sponsor’s reasonable and relevant standard terms and conditions.

COMPLIANCE PLAN/PROGRAM INTEGRITY

PDP Sponsor agrees that it will develop and implement a compliance plan that applies to its Part D-related operations, consistent with 42 CFR §423.504(b)(4)(vi).

The PDP sponsor agrees to provide notice based on best knowledge, information, and belief to CMS of any integrity items related to payments from governmental entities, both federal and state, for healthcare or prescription drug services that would have been reported as part of 3.1.4 of the PDP application. These items include any investigations, legal actions or matters subject to arbitration brought involving the sponsor (or sponsor’s firm if applicable) and its subcontractors (excluding contracted network providers), including any key management or executive staff, or any major shareholders (5% or more), by a government agency (state or federal) on matters relating to payments from governmental entities, both federal and state, for healthcare and/or prescription drug services. In providing the notice, the sponsor shall keep the government informed of when the integrity item is initiated and when it is closed. Notice should be provided of the details concerning any resolution and monetary payments as well as any settlement agreements or corporate integrity agreements.

The PDP Sponsor agrees to provide notice based on best knowledge, information, and belief to CMS in the event the Sponsor or any of its subcontractors is criminally convicted or has a civil judgment entered against it for fraudulent activities or is sanctioned under any Federal program involving the provision of

health care or prescription drug services.

LOW-INCOME SUBSIDY

PDP Sponsor agrees that it will participate in the administration of subsidies for low-income individuals according to Subpart P of 42 CFR Part 423.

COMMUNICATION WITH CMS

PDP Sponsor agrees that it shall maintain the capacity to communicate with CMS electronically in accordance with CMS requirements.

BENEFICIARY FINANCIAL PROTECTIONS

The PDP Sponsor agrees to afford its enrollees protection from liability for payment of fees that are the obligation of the PDP Sponsor in accordance with 42 CFR §423.505(g).

RELATIONSHIP WITH RELATED ENTITIES, CONTRACTORS, AND

SUBCONTRACTORS

The PDP Sponsor agrees it maintains ultimate responsibility for adhering to and otherwise fully complying with all terms and conditions of this contract with CMS.

The PDP Sponsor shall ensure that any contracts or agreements with subcontractors or agents performing functions on the PDP Sponsor’s behalf related to the operation of the Part D benefit are in compliance with 42 CFR §423.505(i).

The PDP Sponsor agrees to act in accordance with 45 CFR Part 76 and agrees that it will not contract with or employ entities or individuals that are excluded by the Department of Health and Human Services, Office of the Inspector General or included on the Excluded Parties List System maintained by the General Services Administration.

CERTIFICATION OF DATA THAT DETERMINE PAYMENT

PDP Sponsor must provide certifications in accordance with 42 CFR §423.505(k).

ENROLLMENT RELATED COSTS

PDP Sponsor agrees to payment of fees established by CMS for cost sharing of enrollment related costs in accordance with 42 CFR §423.6. 6

Article III
Record Retention and Reporting Requirements

RECORD MAINTENANCE AND ACCESS

PDP Sponsor agrees to maintain records and provide access in accordance with 42 CFR §§423.504(d), and 423.505(d) and (e).

GENERAL REPORTING REQUIREMENTS

The PDP Sponsor agrees to submit information to CMS according to 42 CFR §§423.505(f), 423.514, and the “Final Medicare Part D Reporting Requirements,” a document issued by CMS and subject to modification each program year.

LICENSURE-RELATED REPORTING REQUIREMENTS

If the PDP Sponsor is operating under a CMS-granted licensure waiver in any State, the PDP Sponsor agrees to notify CMS in writing of the State’s disposition of the Sponsor’s license application within ten business days of the date that it receives notice of the State’s action.

For those States where the PDP Sponsor is operating under a risk-bearing license, the Sponsor agrees to provide written notice to CMS of the State’s non-renewal of the Sponsor’s license within ten days of receiving notice of the State’s action.

In the event that a State regulator imposes a sanction against the PDP Sponsor or requires the implementation of a corrective action plan, the Sponsor agrees to provide written notice to CMS of such sanction or corrective action requirement (including basis for the sanction and/or timeline for corrective action) within ten days of receiving notice of the State’s action.

In the event that there is a change in the status of the PDP Sponsor’s risk-bearing license in any State (e.g., suspension, revocation), the Sponsor agrees to provide written notice to CMS of the change in status (including basis for the change in status and effective date) within ten days of receiving notice of the State’s action.

If the PDP Sponsor is operating a Part D benefit under a CMS-granted waiver in every State in its service area, and the Sponsor is terminating or reducing the amount of an existing letter of credit obtained for the purposes of funding projected losses, the Sponsor shall provide written notice to CMS of such action 30 days prior to its effective date. The PDP Sponsor agrees that it must obtain CMS approval prior to terminating or reducing the amount of a letter of credit obtained for the purposes of funding projected losses under Appendix X of the PDP Solicitation.

CMS License For Use of Plan Formulary

PDP Sponsor agrees to submit to CMS each plan’s formulary information, including any changes to its formularies, and hereby grants to the Government[, and any person or entity who might receive the formulary from the Government,] 7

a non-exclusive license to use all or any portion of the formulary for any purpose related to the administration of the Part D program, including without limitation publicly distributing, displaying, publishing or reconfiguration of the information in any medium, including www.medicare.gov, and by any electronic, print or other means of distribution.

Article IV
HIPAA Provisions

HIPAA TRANSACTIONS/PRIVACY/SECURITY

PDP Sponsor agrees to comply with the confidentiality and enrollee record accuracy requirements specified in 42 CFR §423.136.

PDP Sponsor agrees to enter into a business associate agreement with the entity with which CMS has contracted to track Medicare beneficiaries’ true out-of- pocket costs.

Article V
Requirements of Other Laws and Regulations

The PDP Sponsor agrees to comply with (a) applicable Federal laws and regulations designed to prevent fraud, waste, and abuse, including, but not limited to applicable provisions of Federal criminal law, the False Claims Act (31 U.S.C. §§3729 et seq.), and the anti-kickback provision of section 1128B of the Act; (b) applicable HIPAA Administrative Simplification Security and Privacy rules at 45 CFR parts 160, 162, and 164; and (c) all other applicable Federal statutes and regulations.

Article VI
Contract Term and Renewal

TERM OF CONTRACT

This contract is effective from the date of CMS’ authorized representative’s signature through December 31, 2006. This contract shall be renewable for successive one-year periods thereafter according to 42 CFR §423.506. PDP Sponsor shall not
conduct Part D-related marketing activities prior to October 1, 2005 and shall not process enrollment applications prior to November 15, 2005. PDP Sponsor shall begin delivering prescription drug benefit services on January 1, 2006.

QUALIFICATION TO RENEW A CONTRACT

In accordance with 42 CFR §423.507, the PDP Sponsor will be determined

qualified to renew its contract annually only if-

(a) CMS informs the PDP Sponsor that it is qualified to renew its

contract; and

(b)

The PDP Sponsor has not provided CMS with a notice of intention

not to renew in accordance with Article VII of this contract.

Although PDP Sponsor may be determined qualified to renew its contract under this Article, if the PDP Sponsor and CMS cannot reach agreement on the bid under Subpart F of 42 CFR Part 423, no renewal takes place, and the failure to reach agreement is not subject to the appeals provisions in Subpart N of 42 CFR Part 423.

Article VII
Nonrenewal of Contract

A. NONRENEWAL BY THE PDP SPONSOR

The PDP Sponsor may elect not to renew its contract with CMS, effective at the

end of the term of the contract for any reason as long as PDP Sponsor provides proper notice of the decision according to the required timeframes.

If the PDP Sponsor does not intend to renew its contract, it must

notify -

(a)

CMS in writing by the first Monday of June in the year in which the current contract period ends;

(b)

Each Medicare enrollee, at least 90 days before the date on which the

nonrenewal is effective. This notice must include a written description of alternatives available for obtaining qualified prescription drug coverage within the PDP region, including Medicare Advantage-Prescription Drug plans,
Medicare cost plans offering a Part D plan, and other PDPs, and must receive CMS approval prior to issuance; and

(c)

The general public, at least 90 days before the end of the current calendar

year, by publishing a notice in one or more newspapers of general circulation in each community or county located in the Part D plan sponsor’s service area.

If the PDP Sponsor does not renew a contract CMS cannot enter into a contract

with the organization for 2 years unless there are special circumstances that warrant special consideration, as determined by CMS.

If the PDP Sponsor does not renew a contract, it must ensure the timely transfer of any data or files in accordance with CMS instructions.

NONRENEWAL BY CMS

CMS may determine that the PDP Sponsor is not qualified to renew its contract for any of the following reasons:

(a)

The reasons listed in 42 CFR §423.509(a) that also permit CMS to terminate

the contract.

(b) The PDP Sponsor has committed any of the acts in 42 CFR §423.752 that 9

support the imposition of intermediate sanctions or civil money penalties under 42 CFR §423.750.

CMS will provide notice of its decision whether the PDP Sponsor is qualified to renew its contract as follows:

(i) To the PDP Sponsor by May 1 of the current contract year.

(ii)

If CMS decides that the PDP Sponsor is not qualified to renew its contract, to

the PDP Sponsor’s Medicare enrollees by mail at least 90 days before the end of the current calendar year.

(iii) If CMS determines that the PDP Sponsor is not qualified to renew its

contract, to the general public at least 90 days before the end of the current calendar year, by publishing a notice in one or more newspapers of general circulation in each community or county located in the PDP Sponsor’s service
area.

(iv)

CMS will provide the notice described in (B)(2)(ii)and (iii) of this Article

where a non-renewal results because CMS and the PDP Sponsor are unable to reach agreement on the bid under 42 CFR Part 423, Subpart F.

CMS shall give the PDP Sponsor written notice of its right to appeal the decision that the sponsor is not qualified renew its contract in accordance with 42 CFR §423.642(b).

Article VIII
Modification or Termination of Contract

CONTRACT MODIFICATION OR TERMINATION BY MUTUAL CONSENT

This contract may be modified or terminated at any time by written mutual consent of the parties.

If this contract is terminated by mutual consent, the PDP Sponsor must provide notice to its Medicare enrollees and the general public in accordance with CMS’s instructions.

If the contract is modified by mutual consent, the PDP Sponsor must notify its Medicare enrollees of any changes that CMS determines are appropriate for notification according to the process and timeframes specified by CMS.

4. If a contract is terminated under section A of this Article, the PDP Sponsor

must ensure the timely transfer of any data or flies.

TERMINATION OF CONTRACT BY CMS

CMS may terminate the contract in accordance with 42 CFR §423.509.

TERMINATION OF CONTRACT BY THE PDP SPONSOR

The PDP Sponsor may terminate the contract only in accordance with 42 CFR §423.510.

Article IX
Intermediate Sanctions

Consistent with Subpart O of 42 CFR Part 423, the PDP Sponsor shall be subject to sanctions and civil money penalties.

Article X
Severability

Severability of the contract shall be in accordance with 42 CFR 423.504(e).

Article XI
Miscellaneous

DEFINITIONS

Terms not otherwise defined in this contract shall have the meaning given to such terms in 42 CFR Part 423.

ALTERATION TO ORIGINAL CONTRACT TERMS

The PDP Sponsor agrees that it has not altered in any way the terms of the PDP contract presented for signature by CMS. PDP Sponsor agrees that any alterations to the original text the PDP Sponsor may make to this contract shall not be binding on the parties.

ADDITIONAL CONTRACT TERMS

The PDP Sponsor agrees to include in this contract other terms and conditions in accordance with 42 CFR §423.505(j).

CMS APPROVAL TO BEGIN MARKETING AND ENROLLMENT ACTIVITIES

PDP Sponsor agrees that it must complete CMS operational requirements prior to receiving CMS approval to begin Part D marketing and enrollment activities. Such activities include, but are not limited to, establishing and successfully testing connectivity, with CMS systems to process enrollment applications (or contracting with an entity qualified to perform such functions on PDP Sponsor’s behalf) and successfully demonstrating capability to submit accurate and timely price comparison data. To establish and successfully test connectivity, the PDP Sponsor must, 1) establish and test physical connectivity to the CMS data center, 2) acquire user identifications and passwords, 3) receive, store, and maintain data necessary to

perform enrollments and send and receive transactions to and from CMS, and 4) check and receive transaction status information.

In witness whereof, the parties hereby execute this contract.

FOR THE PDP SPONSOR


Todd S. Farha		President & C.E.O.

Printed Name		Title

/s/ Todd S. Farha		9-6-05

Signature		Date


WellCare Prescription Insurance, Ine.8725 Henderson Road, Ren. 2 Tampa, FL 33634
Organization Address

FOR THE CENTERS FOR MEDICARE & MEDICAID SERVICES


/s/ Cynthia Tudor for		9/30/05

Robert Donnelly		Date

Director
Medicare Drug Benefit Group
Center for Beneficiary Choices

ATTACHMENT A

PART D BENEFIT PLAN(S) — DESCRIPTION

Prescription Drug Plan Attestation of Benefit Plan and Price

WELLCARE HEALTH PLANS

S5967

Date: 09/06/2005

I attest that the following plan numbers as established in the final Plan Benefit Package (PBP) will be operated by the above-stated organization and made available to eligible Medicare beneficiaries in the approved service area during program year 2006.

CMS

Plan

Segment

Plan

Transaction

Part D

Approval

Effective

Version

Name

Plan Type

Type

Premium

Date

Medicare

WellCare

Prescription

035

Signature

Drug Plan

Initial

23.96

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

036

Signature

Drug Plan

Initial

20.59

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

037

Signature

Drug Plan

Initial

17.13

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

038

Signature

Drug Plan

Initial

17.17

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

039

Signature

Drug Plan

Initial

19.80

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

040

Signature

Drug Plan

Initial

21.20

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

041

Signature

Drug Plan

Initial

22.85

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

042

Signature

Drug Plan

Initial

24.87

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

043

Signature

Drug Plan

Initial

25.71

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

044

Signature

Drug Plan

Initial

24.91

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

045

Signature

Drug Plan

Initial

18.70

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

046

Signature

Drug Plan

Initial

26.46

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

047

Signature

Drug Plan

Initial

24.49

08/31/2005

01/01/2006

Page 1 – WELLCARE HEALTH PLANS – S5967 – 09/06/2005

CMS

Plan

Segment

Plan

Transaction

Part D

Approval

Effective

Version

Name

Plan Type

Type

Premium

Date

Medicare

WellCare

Prescription

048

Signature

Drug Plan

Initial

19.96

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

049

Signature

Drug Plan

Initial

27.45

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

050

Signature

Drug Plan

Initial

24.80

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

051

Signature

Drug Plan

Initial

21.31

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

052

Signature

Drug Plan

Initial

23.82

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

053

Signature

Drug Plan

Initial

28.38

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

054

Signature

Drug Plan

Initial

29.22

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

055

Signature

Drug Plan

Initial

25.79

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

056

Signature

Drug Plan

Initial

23.66

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

057

Signature

Drug Plan

Initial

28.86

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

058

Signature

Drug Plan

Initial

26.64

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

059

Signature

Drug Plan

Initial

24.45

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

060

Signature

Drug Plan

Initial

25.40

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

061

Signature

Drug Plan

Initial

26.44

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

062

Signature

Drug Plan

Initial

27.97

08/31/2005

01/01/2006

Page 2 – WELLCARE HEALTH PLANS – S5967 – 09/06/2005

CMS

Plan

Segment

Plan

Transaction

Part D

Approval

Effective

Version

Name

Plan Type

Type

Premium

Date

Medicare

WellCare

Prescription

063

Signature

Drug Plan

Initial

20.84

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

064

Signature

Drug Plan

Initial

28.14

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

065

Signature

Drug Plan

Initial

32.73

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

066

Signature

Drug Plan

Initial

18.04

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

067

Signature

Drug Plan

Initial

19.18

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

068

Signature

Drug Plan

Initial

20.05

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

069

Complete

Drug Plan

Initial

42.51

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

070

Complete

Drug Plan

Initial

38.61

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

071

Complete

Drug Plan

Initial

33.34

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

072

Complete

Drug Plan

Initial

36.29

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

073

Complete

Drug Plan

Initial

39.83

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

074

Complete

Drug Plan

Initial

38.29

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

075

Complete

Drug Plan

Initial

43.07

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

076

Complete

Drug Plan

Initial

45.22

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

077

Complete

Drug Plan

Initial

45.02

08/31/2005

01/01/2006

Page 3 – WELLCARE HEALTH PLANS – S5967 – 09/06/2005

CMS

Plan

Segment

Plan

Transaction

Part D

Approval

Effective

Version

Name

Plan Type

Type

Premium

Date

Medicare

WellCare

Prescription

078

Complete

Drug Plan

Initial

44.69

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

079

Complete

Drug Plan

Initial

38.44

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

080

Complete

Drug Plan

Initial

45.10

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

081

Complete

Drug Plan

Initial

42.16

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

082

Complete

Drug Plan

Initial

41.56

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

083

Complete

Drug Plan

Initial

47.99

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

084

Complete

Drug Plan

Initial

42.24

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

085

Complete

Drug Plan

Initial

40.97

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

086

Complete

Drug Plan

Initial

44.29

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

087

Complete

Drug Plan

Initial

46.96

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

088

Complete

Drug Plan

Initial

49.46

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

089

Complete

Drug Plan

Initial

45.06

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

090

Complete

Drug Plan

Initial

44.91

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

092

Complete

Drug Plan

Initial

47.25

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

093

Complete

Drug Plan

Initial

45.66

08/31/2005

01/01/2006

Page 4 – WELLCARE HEALTH PLANS – S5967 – 09/06/2005

CMS

Plan

Segment

Plan

Transaction

Part D

Approval

Effective

Version

Name

Plan Type

Type

Premium

Date

Medicare

WellCare

Prescription

094

Complete

Drug Plan

Initial

43.41

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

095

Complete

Drug Plan

Initial

41.81

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

096

Complete

Drug Plan

Initial

45.09

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

097

Complete

Drug Plan

Initial

42.43

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

098

Complete

Drug Plan

Initial

41.00

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

099

Complete

Drug Plan

Initial

45.65

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

100

Complete

Drug Plan

Initial

50.68

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

101

Complete

Drug Plan

Initial

34.79

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

102

Complete

Drug Plan

Initial

34.74

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

103

Complete

Drug Plan

Initial

40.41

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

104

Premier

Drug Plan

Initial

45.48

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

105

Premier e

Drug Plan

Initial

41.25

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

106

Premier

Drug Plan

Initial

35.49

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

107

Premier

Drug Plan

Initial

38.82

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

108

Premier

Drug Plan

Initial

42.67

08/31/2005

01/01/2006

Page 5 – WELLCARE HEALTH PLANS – S5967 – 09/06/2005

CMS

Plan

Segment

Plan

Transaction

Part D

Approval

Effective

Version

Name

Plan Type

Type

Premium

Date

Medicare

WellCare

Prescription

109

Premier

Drug Plan

Initial

41.07

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

110

Premier

Drug Plan

Initial

46.45

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

111

Premier

Drug Plan

Initial

48.99

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

112

Premier

Drug Plan

Initial

48.85

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

113

Premier

Drug Plan

Initial

48.53

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

114

Premier

Drug Plan

Initial

41.41

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

115

Premier

Drug Plan

Initial

48.95

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

116

Premier

Drug Plan

Initial

45.35

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

117

Premier

Drug Plan

Initial

45.05

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

118

Premier

Drug Plan

Initial

52.23

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

119

Premier

Drug Plan

Initial

44.91

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

120

Premier

Drug Plan

Initial

43.75

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

121

Premier

Drug Plan

Initial

47.98

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

122

Premier

Drug Plan

Initial

50.74

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

123

Premier

Drug Plan

Initial

53.70

08/31/2005

01/01/2006

Page 6 – WELLCARE HEALTH PLANS – S5967 – 09/06/2005

CMS

Plan

Segment

Plan

Transaction

Part D

Approval

Effective

Version

Name

Plan Type

Type

Premium

Date

Medicare

WellCare

Prescription

124

Premier

Drug Plan

Initial

48.96

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

125

Premier

Drug Plan

Initial

48.28

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

126

Premier

Drug Plan

Initial

50.98

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

127

Premier

Drug Plan

Initial

48.81

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

128

Premier

Drug Plan

Initial

45.97

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

129

Premier

Drug Plan

Initial

44.22

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

130

Premier

Drug Plan

Initial

48.30

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

131

Premier

Drug Plan

Initial

44.99

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

132

Premier

Drug Plan

Initial

43.81

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

133

Premier

Drug Plan

Initial

48.75

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

134

Premier

Drug Plan

Initial

54.21

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

135

Premier

Drug Plan

Initial

36.60

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

136

Premier

Drug Plan

Initial

36.40

08/31/2005

01/01/2006

Medicare

WellCare

Prescription

137

Premier

Drug Plan

Initial

42.64

08/31/2005

01/01/2006


/s/ Todd S. Farha		9/07/05

CEO:		Date:

Page 7 – WELLCARE HEALTH PLANS – S5967 – 09/06/2005

Todd Farha
CEO/President
PO Box 26011

Tampa, FL ###-###-####
888 ###-###-####


/s/ Paul Behrens		9/7/05

CFO:		Date:

Paul Behrens
Chief Financial Officer
PO Box 26011

Tampa, FL ###-###-####
888 ###-###-#### (1469)

Page 8 – WELLCARE HEALTH PLANS – S5967 – 09/06/2005